title: Troglitazone: a new antihyperglycemic agent.
abstract: Troglitazone is the first of a new family of antihyperglycemic drugs. We review its use in clinical practice.
authors.affiliation: Cleveland Clinic, Cleveland Clinic Foundation, OH 44195, USA.
authors.forename: D G
authors.initials: DG
authors.lastname: Vidt
authors.forename: R A
authors.initials: RA
authors.lastname: Speerhas
authors.forename: S S
authors.initials: SS
authors.lastname: Reddy
mesh_terms: D002839:Chromans / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D005943:Gluconeogenesis / Q000187:drug effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007333:Insulin Resistance; D013844:Thiazoles / Q000627:therapeutic use*; D045162:Thiazolidinediones; D000077288:Troglitazone
chemical_list: D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone